| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $37.9M | -62.3% |
| Cost of Revenue | $0 | -100.0% |
| R&D Expense | $76.9M | -66.7% |
| SG&A Expense | $43.9M | -36.7% |
| Operating Income | -$115.4M | +51.4% |
| Pre-tax Income | -$57.2M | +73.7% |
| Income Tax | $0 | — |
| Net Income | -$57.2M | +73.7% |
| EPS (Basic) | -$1.10 | +75.1% |
| EPS (Diluted) | -$1.10 | +75.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $71.2M | -5.0% |
| Accounts Receivable | $7.8M | -42.0% |
| Current Assets | $187.3M | -21.2% |
| Total Assets | $479.5M | -15.2% |
| Current Liabilities | $40.1M | -32.9% |
| Total Liabilities | $268.7M | -13.4% |
| Stockholders' Equity | $210.8M | -17.4% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$85.0M | +49.1% |
| Capital Expenditures | $707K | -94.9% |
| Investing Cash Flow | $80.8M | +84.1% |
| Financing Cash Flow | $417K | -99.7% |
| Free Cash Flow | -$85.7M | +52.6% |